Literature DB >> 21718065

Quaternary α,α-2-oxoazepane α-amino acids: synthesis from ornithine-derived β-lactams and incorporation into model dipeptides.

Diego Núñez-Villanueva1, M Ángeles Bonache, Lourdes Infantes, M Teresa García-López, Mercedes Martín-Martínez, Rosario González-Muñiz.   

Abstract

To explore further the chemistry of amino acid-derived β-lactams, their conversion to α,α-heterocyclic quaternary amino acid derivatives is investigated. The latter derivatives, containing 2-oxoazepane as the α,α-substituent, are synthesized by a simple Pd-C-catalyzed hydrogenolysis of Orn(Z)-derived 2-azetidinones. The rearrangement from four- to seven-membered lactam ring is driven by the key intramolecular opening of the 1-Boc-β-lactam, initiated by 7-exotrig ring closure from the NH(2) of the Orn side chain. The synthetic route is applied to the stereoselective preparation of enantiomerically pure 4-amino-3-methyl-2-oxoazepane-4-carboxylate derivatives, for which the structure and configuration is confirmed by X-ray diffraction. Molecular modeling and NMR experiments indicate that these quaternary amino acids are able to drive the adoption of β-turn secondary structures when incorporated in model dipeptide derivatives.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21718065     DOI: 10.1021/jo200894d

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

1.  Crystal structure of (4R,5S,6R)-6-azido-5-benz-yloxy-3,3,4-tri-fluoro-azepan-1-ium 2,2,2-tri-fluoro-acetate from synchrotron data.

Authors:  Alpesh Ramanlal Patel; Mohan M Bhadbhade; Fei Liu
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-10-24

2.  Asymmetric Ugi 3CR on isatin-derived ketimine: synthesis of chiral 3,3-disubstituted 3-aminooxindole derivatives.

Authors:  Giordano Lesma; Fiorella Meneghetti; Alessandro Sacchetti; Mattia Stucchi; Alessandra Silvani
Journal:  Beilstein J Org Chem       Date:  2014-06-18       Impact factor: 2.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.